News | September 26, 2024
Pfizer withdraws all lots of sickle cell disease treatment voxelotor
Pfizer's decision is based on the totality of clinical data
Pfizer's decision is based on the totality of clinical data
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Subscribe To Our Newsletter & Stay Updated
